COR2ED - Rare Diseases Medical Conversation
autor: COR2ED Medical Education
Think narcolepsy: Why early recognition and referral matter in an…
O tym podcaście
Join medical experts as they discuss their approaches to identifying, treating, and managing rare diseases, like primary biliary cholangitis, neuroendocrine tumours, rare bone diseases, and growth disorders. The conversations also explore the evolving treatment landscape, including exciting innovations in gene therapies and the use of somatostatin analogues.
This independent medical education podcast is for HCPs with the ultimate goal of improving care for their patients. For more information, visit www.cor2ed.com
Odcinki
Najnowsze 20 z 23 odcinków
- Think narcolepsy: Why early recognition and referral matter in an evolving treatment landscape · 17 min · Sezon 6Join experts Dr Markus Schmidt and Dr Anna Heidbreder as they discuss the importance of early recognition and referral in narcolepsy type 1 (NT1), particularly as new targeted…
- Understanding EP-NEC: Through Diagnosis, Treatment, and Support · 27 min · Sezon 5In this podcast, Medical Oncologist, Dr Aman Chauhan and Neuroendocrine Patient Advocate, Susan Meckler-Plummer, discuss extrapulmonary high-grade neuroendocrine carcinomas…
- Exploring the role of targeted radiopharmaceutical treatment in NETs · 22 min · Sezon 5How are advances in radioligand therapy shaping the treatment of neuroendocrine tumours, and what does recent trial evidence tell us? What are the key considerations for patient…
- Short-stature conditions, including SPIGFD · 24 min · Sezon 4Hear from Dr Andrew Dauber and Dr Marta Ramón Krauel in this podcast as they explore short stature conditions, including SPIGFD (severe primary IGF-1 deficiency) / growth hormone…
- Neuroendocrine tumours (NETs) – Shared decision-making. Part 2: Individualising treatment decisions · 23 min · Sezon 5In this second episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins explore shared…
- Neuroendocrine tumours (NETs) – Shared decision-making. Part 1: Patient journey · 30 min · Sezon 5In this first episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins discuss the…
- Regional differences in NET: Treatment and future developments · 21 min · Sezon 4In the second episode of a two-part podcast series, Prof. Martyn Caplin and Prof. Rachel Riechelmann discuss how to optimize treatment for people living with NETs and future…
- Regional differences in NET: Epidemiology, diagnosis, and referral strategies · 22 min · Sezon 4In this first episode of a two-part podcast series, Prof. Martyn Caplin and Prof. Rachel Riechelmann discuss regional differences in NET epidemiology, and patient pathways, as…
- Short stature: Severe primary IGF-I deficiency (SPIGFD). Part 2 · 26 min · Sezon 3Comprehensive biochemical and genetic testing allows for the identification of classical and non-classical forms of primary IGF-I deficiency and can identify overlapping…
- Short stature: Key challenges in diagnosis and management. Part 1 · 34 min · Sezon 3Do you know how to differentiate between growth hormone deficiency (or GHD) and primary IGF-I deficiency (or growth hormone resistance) and the key challenges in the diagnosis…
- Gene therapy and gene-modified cell therapy in rare diseases · 28 min · Sezon 3Gene therapy and gene-modified cell therapies have a great potential for rare diseases to either help patients to cure their disease or improve their lives. Did you know that…
- Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 2 · 23 minRobert Mitchell-Thain, CEO of the PBC Foundation, Edinburgh, UK and Kath Houghton, Autoimmune Specialist Nurse, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK…
- Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 1 · 31 minProf. Gideon Hirschfield, Professor of Medicine, Division of Gastroenterology, University of Toronto, Canada and Dr Emma Culver, Consultant Hepatologist and Honorary Senior…
- Neuroendocrine tumours: The role of SSA at progression - To continue or not? · 33 min · Sezon 2In this podcast, Prof. Martyn Caplin and Dr Aman Chauhan discuss the role of somatostatin analogues (SSAs) at progression and whether to continue or not. In patients with…
- Rare bone disease: Highlights from ASBMR 2022 - Part 3 · 23 min · Sezon 2In this third episode of a three-episode podcast series, COR2ED and ASBMR have partnered with patient advocates Inês Alves (European Rare Bone Forum) and Tracy Hart (Osteogenesis…
- Rare bone disease: Highlights from ASBMR 2022 - Part 2 · 15 min · Sezon 2In this second episode of a three-episode podcast series, COR2ED and ASBMR have partnered with Professor Eric Rush (Children’s Mercy Hospital) to provide rare bone disease…
- Rare bone disease: Highlights from ASBMR 2022 - Part 1 · 17 min · Sezon 2In this first episode of a three-episode podcast series, COR2ED and ASBMR have partnered with Professor Anna Teti (University of L’Aquila) to provide rare bone disease highlights…
- Primary Biliary Cholangitis (PBC): Highlights from ILC 2022. Part 2 · 20 min · Sezon 2In this podcast episode, Prof. Kris Kowdley, Director, Liver Institute Northwest, Washington State University, USA and Prof. Jörn Schattenberg, Director, Metabolic Liver…
- Primary Biliary Cholangitis (PBC): Highlights from ILC 2022. Part 1 · 19 min · Sezon 2In this podcast, Prof. Gideon Hirschfield, Professor of Medicine, Division of Gastroenterology, University of Toronto, Canada and Prof. Ana Lleo, Professor of Internal Medicine…
- Rare bone disease: Highlights from ASBMR 2021. Part 4 · 14 min · Sezon 1We have partnered with international experts to provide rare bone disease highlights from ASBMR 2021. This is the final episode in a series of four podcasts, in this episode Dr…








